BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33319489)

  • 1. Functional inhibition of heat shock protein 70 by VER-155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism.
    Sakai K; Inoue M; Mikami S; Nishimura H; Kuwabara Y; Kojima A; Toda M; Ogawa-Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Kyoyama H; Moriyama G; Shiibashi M; Seike M; Gemma A; Uematsu K
    Thorac Cancer; 2021 Feb; 12(4):491-503. PubMed ID: 33319489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation.
    Favoni RE; Pattarozzi A; Lo Casto M; Barbieri F; Gatti M; Paleari L; Bajetto A; Porcile C; Gaudino G; Mutti L; Corte G; Florio T
    Curr Cancer Drug Targets; 2010 Mar; 10(2):176-91. PubMed ID: 20088784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.
    Wen W; Liu W; Shao Y; Chen L
    Exp Biol Med (Maywood); 2014 May; 239(5):638-45. PubMed ID: 24676905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
    Yamaji M; Ota A; Wahiduzzaman M; Karnan S; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Haniuda M
    Cancer Med; 2017 Nov; 6(11):2646-2659. PubMed ID: 28960945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors.
    Echeverry N; Ziltener G; Barbone D; Weder W; Stahel RA; Broaddus VC; Felley-Bosco E
    Cell Death Dis; 2015 May; 6(5):e1757. PubMed ID: 25950487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
    Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
    J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
    Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
    Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo.
    Miyoshi S; Hamada H; Hamaguchi N; Kato A; Katayama H; Irifune K; Ito R; Miyazaki T; Okura T; Higaki J
    Int J Oncol; 2012 Aug; 41(2):449-56. PubMed ID: 22580933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.
    Parvathaneni V; Chilamakuri R; Kulkarni NS; Wang X; Agarwal S; Gupta V
    Life Sci; 2022 Oct; 306():120843. PubMed ID: 35908620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
    Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
    Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
    Jänne PA; Taffaro ML; Salgia R; Johnson BE
    Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets.
    Barbieri F; Würth R; Favoni RE; Pattarozzi A; Gatti M; Ratto A; Ferrari A; Bajetto A; Florio T
    Biochem Pharmacol; 2011 Nov; 82(10):1467-77. PubMed ID: 21787763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma.
    Okamoto J; Mikami I; Tominaga Y; Kuchenbecker KM; Lin YC; Bravo DT; Clement G; Yagui-Beltran A; Ray MR; Koizumi K; He B; Jablons DM
    J Thorac Oncol; 2008 Oct; 3(10):1089-95. PubMed ID: 18827603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing and Quantifying the Effect of the Inhibition of HSP70 on Breast Cancer Cells Based on Laser Scanning Microscopy.
    Yu B; Yang H; Zhang X; Li H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818785274. PubMed ID: 30175665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.
    Kaku Y; Nagaya H; Tsuchiya A; Kanno T; Gotoh A; Tanaka A; Shimizu T; Nakao S; Tabata C; Nakano T; Nishizaki T
    Cancer Sci; 2014 Jul; 105(7):883-9. PubMed ID: 24754309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
    Cavanaugh A; Juengst B; Sheridan K; Danella JF; Williams H
    Oncotarget; 2015 Nov; 6(37):39821-38. PubMed ID: 26556859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages.
    Yuan BZ; Chapman J; Ding M; Wang J; Jiang B; Rojanasakul Y; Reynolds SH
    BMC Cancer; 2013 Mar; 13():140. PubMed ID: 23517112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma.
    Huang L; Wang Y; Bai J; Yang Y; Wang F; Feng Y; Zhang R; Li F; Zhang P; Lv N; Lei L; Hu J; He A
    Cell Stress Chaperones; 2020 Mar; 25(2):357-367. PubMed ID: 32026316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.